Association of Serum Leptin and Adiponectin Concentrations with Type 2 Diabetes Biomarkers and Complications Among Saudi Women
Walaa Mohammed Saeed,Dalal Nasser Binjawhar
DOI: https://doi.org/10.2147/DMSO.S405476
2023-07-14
Abstract:Walaa Mohammed Saeed, 1 Dalal Nasser Binjawhar 2 1 Department of Medical Laboratory Technology, Faculty of Applied Medical Science, Taibah University, Tayba, Medina, 42353, Saudi Arabia; 2 Department of Chemistry, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, 11671, Saudia Arabia Correspondence: Dalal Nasser Binjawhar, Email Objective: Hyperglycemia and insulin resistance (IR) put obese women with Type 2 diabetes mellitus (T2DM) at risk for cardiovascular disease (CVD). Methods: 150 T2DM women aged 30– 45 were studied cross-sectionally at Madinah Hospital lab to find T2DM risk factors and their association with adiponectin/leptin levels. Results: Women with T2DM showed greater fasting blood glucose (FBG), hemoglobin A1c (HbA1c), triglycerides (TG), body mass index (BMI), waist circumference (WC), insulin resistance (IR), high-sensitivity C-reactive protein (hs-CRP), and CVD risk (high atherogenic index of plasma (AIP) and leptin), but decreased high-density lipoprotein (HDL-cholesterol) and poor insulin sensitivity with low adiponectin. Obese women with T2DM had increased leptin and reduced adiponectin. Leptin levels were significantly related to IR, BMI, and AIP (B= 3.97, P= 0.02) but not WC. Leptin levels were negatively correlated with insulin sensitivity (IS) and HDL-c (P Conclusion: Increased leptin levels are related to high IR, AIP, and BMI among T2DM female patients. Similarly, adiponectin levels decrease IS and HDL-c. Therefore, obese T2DM women with high leptin and low adiponectin levels should be periodically checked to avoid or decrease consequences like CVD. Keywords: adiponectin, cardiovascular disease, insulin resistance, leptin, obesity, type 2 diabetes Type 2 diabetes mellitus (T2DM) accounts for 90% of all diabetes cases and can be characterized by hyperglycemia, insulin resistance (IR), and insufficiency. It is reported that diabetes mellitus (DM) has a substantial economic impact; the indirect national financial burden is anticipated to be over 0.87 billion USD, and patients with diabetes have about ten times greater healthcare expenses than those without diabetes (3686 ). 1–3 Diabetes affects 31.6% of Saudi Arabia's (KSA) population, among which 27.6% are women. 4 Reportedly, cardiovascular disease (CVD) is a prevalent consequence of DM, and it continues to be the major cause of mortality and disability among DM patients. According to a Saudi Scientific Diabetes Society research, > 50% of DM patients die from cardiovascular reasons. The number of DM patients with higher cardiovascular risk is predicted to provide a significant challenge to the healthcare systems of KSA, and the proportion of DM survivors of cardiovascular events is rising globally. 5 According to World Health Organization 2021 reports, 33.7% of Saudis are obese, and 68.2% are overweight, demonstrating that preventive measures are missing or inefficient. 5,6 Obese people are at risk for diabetes, CVD, stroke, cancer, and obstructive sleep apnea. Better knowledge of DM, CVD, and obesity pathogeneses linkages is needed to create innovative techniques for lowering patient health problems and discovering new diagnostic biomarkers. Leptin is a 16-kDa protein hormone that regulates appetite and energy balance. Leptin has a key function in the pathogenesis of obesity and IR. 7 Experimental investigations show that serum leptin regulates brain glucose. Some studies found a high connection between diabetes biomarkers and leptin levels, 8 while others found none. 7 Adiponectin, another adipokine, protects against IR/diabetes and atherosclerosis. Reduced adiponectin levels may contribute to T2DM, obesity, and CVD. Adiponectin regulates insulin sensitivity, glucose, lipid metabolism, and cardiovascular homeostasis. 9 Leptin and adiponectin are hormones secreted from adipose tissue; leptin promotes metabolism and lowers hunger, while adiponectin mediates insulin-sensitizing action. Abnormal levels of leptin are linked to obesity and IR. Greater adipose tissue (body fat) mass and IR raise leptin levels, whereas higher body fat mass and insulin sensitivity reduce adiponectin levels. As Saudi females have a greater incidence of T2DM, obesity, and CVD, leptin and adiponectin levels with T2DM biomarkers and comorbidities were evaluated with the expectation that leptin, adiponectin, and T2DM consequences, including CVD, would be linked to obese status. Cross-sectional research was done between 2021 −2022 on 150 women with T2DM aged between 30–45. In contrast, T2DM was defined by hemoglobin A1c (HbA1c) 6.5% (48 mmol/mol), fasting blood glucose (FBG) ≥126mg/dL, self-reported use of insulin or oral hypogly -Abstract Truncated-
endocrinology & metabolism